Clinical Trial Update: A Comparative Evaluation of Pharmacokinetics and Immunogenicity. [Phase 1]

View source ↗

Summary

Phase 1 trial by Kashiv BioSciences evaluating pharmacokinetics and immunogenicity of an investigational product in febrile neutropenia. The study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Snippet

Sponsor: Kashiv BioSciences, LLC | Conditions: Febrile Neutropenia | Phase 1 | Status: COMPLETED